Vicore Pharma Holding AB (OSTO:VICO) E10: kr-2.51 (As of Mar. 2026)


OSTO:VICO Vicore Pharma Holding AB OSTO:VICO
28 GF Score
Price kr12.12
! 3 Warning Signs
View Full Analysis

What is Vicore Pharma Holding AB E10?

Vicore Pharma Holding AB OSTO:VICO +1.85% 28 E10 is kr-2.51 as of Mar. 2026. GuruFocus rates OSTO:VICO with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vicore Pharma Holding AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-0.390. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-2.51 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-26), Vicore Pharma Holding AB's current stock price is kr12.12. Vicore Pharma Holding AB's E10 for the quarter that ended in Mar. 2026 was kr-2.51. Vicore Pharma Holding AB's Shiller PE Ratio of today is .


Vicore Pharma Holding AB  (OSTO:VICO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vicore Pharma Holding AB E10 Related Terms


Vicore Pharma Holding AB E10 Historical Data

* Premium members only.

The historical data trend for Vicore Pharma Holding AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicore Pharma Holding AB E10 Chart

Vicore Pharma Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.34 -2.49

Vicore Pharma Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.37 -2.42 -2.45 -2.49 -2.51

OSTO:VICO vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Vicore Pharma Holding AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicore Pharma Holding AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's Shiller PE Ratio falls into.


OSTO:VICO
28GF Score
Vicore Pharma Holding AB OSTO:VICO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vicore Pharma Holding AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vicore Pharma Holding AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.39/133.3862*133.3862
=-0.390

Current CPI (Mar. 2026) = 133.3862.

Vicore Pharma Holding AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.093 101.019 -0.123
201609 -0.085 101.138 -0.112
201612 -0.124 102.022 -0.162
201703 -0.137 102.022 -0.179
201706 -0.128 102.752 -0.166
201709 -0.107 103.279 -0.138
201712 -0.992 103.793 -1.275
201803 -0.010 103.962 -0.013
201806 0.389 104.875 0.495
201809 -0.632 105.679 -0.798
201812 -0.525 105.912 -0.661
201903 -0.389 105.886 -0.490
201906 -0.613 106.742 -0.766
201909 -0.525 107.214 -0.653
201912 -0.584 107.766 -0.723
202003 -0.545 106.563 -0.682
202006 -0.467 107.498 -0.579
202009 -0.632 107.635 -0.783
202012 -0.983 108.296 -1.211
202103 -0.739 108.360 -0.910
202106 -0.954 108.928 -1.168
202109 -1.323 110.338 -1.599
202112 -1.090 112.486 -1.293
202203 -1.265 114.825 -1.469
202206 -0.895 118.384 -1.008
202209 -0.924 122.296 -1.008
202212 -0.798 126.365 -0.842
202303 -0.788 127.042 -0.827
202306 -0.827 129.407 -0.852
202309 -0.564 130.224 -0.578
202312 -0.990 131.912 -1.001
202403 0.280 132.205 0.283
202406 -0.500 132.716 -0.503
202409 -0.530 132.304 -0.534
202412 -0.400 132.987 -0.401
202503 -0.480 132.825 -0.482
202506 -0.490 133.699 -0.489
202509 -0.480 133.482 -0.480
202512 -0.540 133.386 -0.540
202603 -0.390 133.386 -0.390

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-2.51 mean?
Vicore Pharma Holding AB (OSTO:VICO) has a E10 of kr-2.51 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vicore Pharma Holding AB and its competitors.
Is Vicore Pharma Holding AB's E10 too high?
Vicore Pharma Holding AB's current E10 is kr-2.51. Overall, Vicore Pharma Holding AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Vicore Pharma Holding AB's E10 compare to VRTX and REGN?
Vicore Pharma Holding AB's E10 of kr-2.51 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vicore Pharma Holding AB and its competitors. Vicore Pharma Holding AB's current E10 is kr-2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicore Pharma Holding AB stock overvalued right now?
Vicore Pharma Holding AB (OSTO:VICO) has a current E10 of kr-2.51. The current E10 is kr-2.51. Vicore Pharma Holding AB's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Vicore Pharma Holding AB (OSTO:VICO), the current E10 is kr-2.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicore Pharma Holding AB Business Description

Other Exchanges 6Y4:Germany
Address Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
28GF Score

Get the complete analysis for OSTO:VICO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.12
Price